Literature DB >> 23123477

Inhibition of human aldose reductase-like protein (AKR1B10) by α- and γ-mangostins, major components of pericarps of mangosteen.

Midori Soda1, Satoshi Endo, Toshiyuki Matsunaga, Hai-Tao Zhao, Ossama El-Kabbani, Munekazu Iinuma, Keiko Yamamura, Akira Hara.   

Abstract

A human member of the aldo-keto reductase (AKR) superfamily, AKR1B10, was recently identified as both diagnostic marker and therapeutic target in the treatment of several types of cancer. In this study, we have examined AKR1B10 inhibition by five xanthone derivatives, components of pericarps of mangosteen, of which α- and γ-mangostins show potential anti-cancer properties. Among the five xanthones, γ-mangostin was found to be the most potent competitive inhibitor (inhibition constant, 5.6 nM), but its 7-methoxy derivative, α-mangostin, was the second potent inhibitor (inhibition constant, 80 nM). Molecular docking of the two mangostins in AKR1B10 and site-directed mutagenesis of the putative binding residues revealed that Phe123, Trp220, Val301 and Gln303 are important for the tight binding of γ-mangostin, and suggested that the 7-methoxy group of α-mangostin impairs the inhibitory potency by altering the orientation of the inhibitor molecule in the substrate-binding site of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123477     DOI: 10.1248/bpb.b12-00538

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.264


  5 in total

1.  In vitro and in vivo characterization of the anticancer activity of Thai stingless bee (Tetragonula laeviceps) cerumen.

Authors:  Pongvit Nugitrangson; Songchan Puthong; Tawin Iempridee; Wittaya Pimtong; Surachai Pornpakakul; Chanpen Chanchao
Journal:  Exp Biol Med (Maywood)       Date:  2015-08-19

2.  Selective Inhibition of Human AKR1B10 by n-Humulone, Adhumulone and Cohumulone Isolated from Humulus lupulus Extract.

Authors:  Jan Moritz Seliger; Serhat Sezai Cicek; Lydia T Witt; Hans-Jörg Martin; Edmund Maser; Jan Hintzpeter
Journal:  Molecules       Date:  2018-11-21       Impact factor: 4.411

Review 3.  Selected Indonesian Medicinal Plants for the Management of Metabolic Syndrome: Molecular Basis and Recent Studies.

Authors:  Wawaimuli Arozal; Melva Louisa; Vivian Soetikno
Journal:  Front Cardiovasc Med       Date:  2020-05-06

4.  (-)-Kusunokinin as a Potential Aldose Reductase Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation.

Authors:  Tanotnon Tanawattanasuntorn; Tienthong Thongpanchang; Thanyada Rungrotmongkol; Chonnikan Hanpaibool; Potchanapond Graidist; Varomyalin Tipmanee
Journal:  ACS Omega       Date:  2020-12-21

Review 5.  Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.

Authors:  Li Huang; Rongzhang He; Weihao Luo; Yuan-Shan Zhu; Jia Li; Tan Tan; Xi Zhang; Zheng Hu; Dixian Luo
Journal:  Recent Pat Anticancer Drug Discov       Date:  2016       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.